Skip to main content

Table 1 Demographic characteristics and clinical features (symptomatic and structural disease severity parameters) in our study population with AS

From: Is there a relation between pre-sarcopenia, sarcopenia, cachexia and osteoporosis in patients with ankylosing spondylitis?

    Minimum Maximum
Age (yrs): m (SD) 40.7 (11.0) 18 66
Disease duration (yrs): m (SD) 9.3 (7.9) 1 36
BASDAI: m (SD) 3.7 (2.4) 0 8.6
BASMI: m (SD) 2.8 (5.5) 0 36
BASFI: m (SD) 40.5 (28.1) 0 83
BAS-G: m (SD) 17.5 (22.7) 0 72
ESR (mm/H): m (SD) 27.1 (21.0) 2 78
CRP (mg/l) : m (SD) 15.3 (25.1) 0.3 168.0
SASSS: m (SD) 10.7 (15.7) 0 72
Anti-TNF use : n (%) 22 (32.9)   
Anti-TNF use duration (yrs): m (SD) 2.3 (1.7) 0.25 7
  1. CRP C-reactive protein, ESR erythrocyte sedimentation rate, SASSS Stoke Ankylosing Spondylitis Spinal Score